Back to LLY
PRICE T ROWE ASSOCIATES INC /MD/ → LLY
PRICE T ROWE ASSOCIATES INC /MD/ LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
8
Latest value
$1.4B
Q3 2026
Peak value
$15.3B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $14.8B |
| Q4 2025 | $1.3B |
| Q1 2026 | $1B |
| Q1 2026 | $11.8B |
| Q2 2026 | $15.3B |
| Q2 2026 | $1.4B |
| Q3 2026 | $14.1B |
| Q3 2026 | $1.4B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.4B | 1.19M | — | — |
| Q3 2026 | $14.1B | 12.20M | — | — |
| Q2 2026 | $1.4B | 1.16M | — | — |
| Q2 2026 | $15.3B | 12.75M | — | — |
| Q1 2026 | $11.8B | 12.85M | — | — |
| Q1 2026 | $1B | 1.14M | — | — |
| Q4 2025 | $1.3B | 1.17M | — | — |
| Q4 2025 | $14.8B | 13.74M | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B